The regulation of BM-MSCs of patients with type 2 diabetes mellitus (T2DM) by SCD-1 is a necessary condition for osteogenesis mediated through the miR-203a/FOS and miR-1908/EXO1 regulatory pathways64. This evidence concerns the gene FOS and type 2 diabetes mellitus.